ANTARES
Phase 2 Recruiting
28 enrolled
Tumor HI
Phase 3 Recruiting
16 enrolled
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Phase 1/2 Recruiting
139 enrolled
TAIS
Phase 2 Recruiting
45 enrolled
Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor
Available
Infantile Versus Adult-type Fibrosarcoma and the Risk of Multiple Primary Malignancies
Completed
12,783 enrolled
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Phase 2 Completed
73 enrolled 11 charts
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
Phase 1 Completed
16 enrolled
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
Phase NA Completed
70 enrolled
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
Phase 2 Completed
54 enrolled 12 charts
VORTEX
Phase 3 Completed
216 enrolled
SINDIR
Phase 2 Unknown
30 enrolled
UN-RESARC
Phase 2 Unknown
46 enrolled
ADCVCTAST
Phase 1/2 Unknown
48 enrolled
Bevacizumab and Radiation Therapy for Sarcomas
Phase 2 Completed
20 enrolled 16 charts
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
Phase 1 Completed
3 enrolled
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
Phase 3 Completed
370 enrolled
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Phase 2 Completed
53 enrolled 6 charts
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Phase 3 Terminated
22 enrolled 9 charts
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma
Phase 2 Terminated
1 enrolled 3 charts
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
Phase 2 Completed
25 enrolled 6 charts
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Phase 2 Completed
Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
Phase 2 Completed
48 enrolled 9 charts
Combination Chemotherapy in Treating Patients With Advanced Cancer
Phase 1/2 Completed